Danemark And NotCecilia L Sser
List of bibliographic references
Number of relevant bibliographic references: 30.Ident. | Authors (with country if any) | Title |
---|---|---|
000290 | Mette Scheller Nissen [Danemark] ; Anna Christine Nilsson [Danemark] ; Jonatan Forsberg [Danemark] ; Jesper Milthers [Danemark] ; Martin Wirenfeldt [Danemark] ; Christian Bonde [Danemark] ; Keld-Erik Byg [Danemark] ; Torkell Ellingsen [Danemark] ; Morten Blaabjerg [Danemark] | Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid Meningitis |
000712 | Eric Santoni-Rugiu [Danemark] ; Linea C. Melchior [Danemark] ; Edyta M. Urbanska [Danemark] ; Jan N. Jakobsen [Danemark] ; Karin De Stricker [Danemark] ; Morten Grauslund [Suède] ; Jens B. S Rensen [Danemark] | Intrinsic Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer: Differences and Similarities with Acquired Resistance |
000714 | Aneesh Thakur [Danemark] ; Heidi Mikkelsen [Danemark] ; Gregers Jungersen [Danemark] | Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies |
000A20 | Serena Galati [Italie] ; Christian Boni [Italie] ; Maria Carla Gerra [Danemark] ; Mirca Lazzaretti [Italie] ; Annamaria Buschini [Italie] | Autophagy: A Player in response to Oxidative Stress and DNA Damage |
000A86 | Sofia Avnet [Italie] ; Nicola Baldini [Italie] ; Lucie Brisson [France] ; Stine Falsig Pedersen [Danemark] ; Paolo E. Porporato [Italie] ; Pierre Sonveaux [Belgique] ; Gyorgy Szabadkai [Italie, Royaume-Uni] ; Silvia Pastorekova [Slovaquie] | Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic Adaptations and Targets in Cancer |
000F78 | Lorenzo Galluzzi [France, Italie] ; Federico Pietrocola [France] ; José Manuel Bravo-San Pedro [France] ; Ravi K. Amaravadi [États-Unis] ; Eric H. Baehrecke [États-Unis] ; Francesco Cecconi [Danemark, Italie] ; Patrice Codogno [France] ; Jayanta Debnath [États-Unis] ; David A. Gewirtz [États-Unis] ; Vassiliki Karantza [États-Unis] ; Alec Kimmelman [États-Unis] ; Sharad Kumar [Australie] ; Beth Levine [États-Unis] ; Maria Chiara Maiuri [France] ; Seamus J. Martin [Irlande (pays)] ; Josef Penninger [Autriche] ; Mauro Piacentini [Italie] ; David C. Rubinsztein [Royaume-Uni] ; Hans-Uwe Simon [Suisse] ; Anne Simonsen [Norvège] ; Andrew M. Thorburn [États-Unis] ; Guillermo Velasco [Espagne] ; Kevin M. Ryan [Royaume-Uni] ; Guido Kroemer [France] | Autophagy in malignant transformation and cancer progression |
001742 | George O. Adjei [Ghana] ; William Kudzi [Ghana] ; Alexander Dodoo [Ghana] ; Jorgen A. L. Kurtzhals [Danemark] | Artesunate plus amodiaquine combination therapy: reviewing the evidence |
001819 | Juha-Matti Alakoskela [Finlande] ; Pavol Vitovi [Finlande] ; Paavo Kinnunen [Finlande, Danemark] | Screening for the Drug–Phospholipid Interaction: Correlation to Phospholipidosis |
001D30 | Nils Milman [Danemark] ; Claus B. Andersen ; Annette Hansen ; Thomas Van Overeem Hansen ; Finn C. Nielsen ; Hans Fledelius ; Peter Ahrens ; Ole Haagen Nielsen [Danemark] | Favourable effect of TNF‐α inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novoCARD15 mutation |
001E21 | Pg Ortiz [Danemark] ; Bg Skov [Danemark] ; E. Benfeldt | α1‐Antitrypsin deficiency‐associated panniculitis: case report and review of treatment options |
002633 | P. B. Jensen [Danemark] ; M. Sehested [Danemark] ; S. W. Langer [Danemark] ; H. H. Hansen [Danemark] | Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory |
002713 | S. W. Langer [Danemark] ; G. Schmidt [Danemark] ; M. S Rensen [Danemark] ; M. Sehested [Danemark] ; P. B. Jensen [Danemark] | Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity |
002728 | P. Oxholm [Danemark] ; K. Asmussen [Danemark] | Standardized assessment of disease status in patients with primary Sjögren's syndrome: the foundation for creating criteria for disease activity and damage? |
002906 | Morten Sorensen [Danemark] ; Maxwell Sehested [Danemark] ; Peter Buhl Jensen [Danemark] | pH-Dependent regulation of camptothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine |
002948 | Peter Buhl Jenen [Danemark] ; Maxwell Sehested [Danemark] | DNA topoisomerase II rescue by catalytic inhibitors |
002A34 | Maxwell Sehested [Danemark] ; Peter Buhl Jensen [Danemark] | Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle |
002A39 | B. Holm [Danemark] ; Peter Buhl Jensen [Danemark] ; Maxwell Sehested [Danemark] | ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors |
002A68 | B. Holm [Danemark] ; P. B. Jensen [Danemark] ; M. Sehested | ICFR-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors |
002C07 | Mette Midttun [Danemark] ; Bjarne O Berg [Danemark] | Total heart block after intravenous metoclopramide |
002D05 | P. B. Jensen [Danemark] ; B. S. S Rensen ; M. Sehested ; P. Grue [Danemark] ; E. J. F. Demant ; H. H. Hansen [Danemark] | Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments |
003027 | Finn C. Nielsen [Danemark] ; Steen Gammeltoft [Danemark] ; Bengt Westermark [Suède] ; Jan Fahrenkrug [Danemark] | High affinity receptors for vasoactive intestinal peptide on a human glioma cell line |
003029 | J. Sonne [Danemark] ; S. Boesgaard [Danemark] ; H. E. Poulsen [Danemark] ; S. Loft [Danemark] ; J. M Lholm Hansen [Danemark] ; M. D Ssing [Danemark] ; F. Andreasen [Danemark] | Glucuronidation of oxazepam and paracetamol in severe hypothyroidism |
003233 | Maxwell Sehested [Danemark] ; Torben Skovsgaard [Danemark] ; Henrik Roed [Danemark] | The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells |
003398 | Niels K. Veien [Danemark] | Cutaneous sarcoidosis: Prognosis and treatment |
003422 | A. G. Jurik [Danemark] ; H. Graudal [Danemark] | Pericarditis in rheumatoid arthritis |
003435 | M. Strate [Danemark] ; F. Brandrup [Danemark] ; P. Wang [Danemark] | Discoid lupus erythematosus‐like skin lesions in a patient with autosomal recessive chronic granulomatous disease |
003513 | Anne Grethe Jurik [Danemark] ; Ulrik Pedersen [Danemark] ; Ge N Rgárd [Danemark] | Rheumatoid arthritis of the cricoarytenoid joints: A case of laryngeal obstruction due to acute and chronic joint changes |
003688 | L. Binderup [Danemark] ; E. Bramm [Danemark] ; E. Arrigoni-Martelli [Danemark] | The effect of some antirheumatic drugs in vivo on the response of spleen cells to concanavalin A in rats with chronic inflammation |
003842 | I. Ahnfelt-R Nne [Danemark] ; E. Arrigoni-Martelli [Danemark] | A new antiinflammatory compound, timegadine ( N -cyclohexyl- N ′′-p-methylquinolyl N ′-Z-thiazolylguanidine), which inhibits both prostaglandin and 12-hydroxyeicosatetraenoic acid (12-HETE) formation |
003962 | N. K. Veien [Danemark] ; H. Brodthagen [Danemark] | Cutaneous sarcoidosis treated with methotrexate |
This area was generated with Dilib version V0.6.33. |